We are live on
!
Find out more
TGI
TRV GP IV Portfolio holdings
AUM
$267M
1-Year Est. Return
965.83%
This Fund
S&P 500
This Quarter
Est. Return
-32.77%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
–
AUM
$80.2M
AUM Growth
-$81.9M
(-51%)
Cap. Flow
-$8.37M
Cap. Flow
% of AUM
-10.43%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fulcrum Therapeutics
FULC
|
+$8.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
OPL
WAM
IP
SIA
CFG
EU
PC
ALC
TRV GP IV's Q4 2024 Portfolio in Review
As of Q4 2024, TRV GP IV held 3 positions worth $80.2M, down 51% from $162M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRV GP IV withdrew a net $8.37M in Q4 2024, closing 1 position. Its most notable exit was Fulcrum Therapeutics, an estimated $8.37M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP IV fully exited Fulcrum Therapeutics in Q4 2024, selling an estimated $8.37M.
- TRV GP IV's ten largest holdings make up 100% of its $80.2M portfolio in Q4 2024.
- TRV GP IV opened 0 new positions and closed 1 in Q4 2024.
- TRV GP IV's portfolio value fell 51% quarter-over-quarter to $80.2M.
Based on TRV GP IV's 13F filing for Q4 2024, filed 13 Feb 2025.